Skip to main content
SpringerLink
Log in

Can GH induce chromosome breaks or microsatellite instability in GH-deficient children?

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The role of GH in carcinogenesis is unclear. We studied the effect of recombinant human GH (rhGH) in vitro on chromosomal and genomic instability. Thirteen children, aged 9.57±1.08 yr (mean±SEM), with complete (no.=5) or partial (no.=8) GH deficiency were evaluated before and during GH treatment. We examined the incidence of chromosome and chromatid breaks, and microsatellite instability after in vitro addition of two different doses of rhGH to peripheral blood lymphocytes obtained from the patients. No differences were observed between the samples of GH-deficient children before and after GH therapy as regards the percentage of chromosome and chromatids breaks, and in microsatellite instability. Our data show that in vitro addition of rhGH does not induce chromosomal and/or genomic instability in cultured lymphocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allen DB, Rundle AC, Graves DA, Blethen SL. Risk of leukemia in children treated with human growth hormone: review and reanalyses. J Pediatr 1997, 131: S32–6.

    Article  CAS  PubMed  Google Scholar 

  2. Rogers PC, Komp D, Rogol A, Sabio H. Possible effect of growth hormone on development of acute lymphoblastic leukemia. Lancet 1977, 2: 434–45.

    Article  CAS  PubMed  Google Scholar 

  3. Zadik Z, Estrov Z, Karov Y, Hahn T, Barak Y. The effect of growth hormone and IGF-I on clonogenic growth of hematopoietic cells in leukemia patients during active disease and during remission: a preliminary report. J Pediatr Endocrinol 1993, 6: 79–83.

    CAS  PubMed  Google Scholar 

  4. Jenkins PJ, Besser M. Acromegaly and cancer: a problem. J Clin Endocrinol Metab 2001, 86: 2935–41.

    Article  CAS  PubMed  Google Scholar 

  5. Swerdlow AJ, Higgins CD, Adlard P, Preece MA. Risk of cancer in patients treated with human pituitary growth hormone in UK, 1959–85: a cohort study. Lancet 2002, 360: 273–7.

    Article  CAS  PubMed  Google Scholar 

  6. Tedeschi B, Spadoni GL, Sanna ML, et al. Increased chromosome fragility in lymphocytes of short normal children treated with recombinant human growth hormone. Hum Genet 1993, 91: 459–63.

    Article  CAS  PubMed  Google Scholar 

  7. 2001 Consensus. Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. J Cin Endocrinol Metab 2001, 86: 1868–70.

    Google Scholar 

  8. Greulich WW, Pyle S. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford: Stanford University Press. 1959.

    Google Scholar 

  9. Shalet SM, Brennan BM, Reddingius RE. Growth hormone therapy and malignancy. Horm Res 1997, 48(Suppl 4): 29–32.

    Article  CAS  PubMed  Google Scholar 

  10. Watanabe S, Tsunematsu Y, Fumimoto J, Komiyama A. Leukemia in patients treated with growth hormone. Lancet 1998, 1: 1159.

    Google Scholar 

  11. Hagmar L, Brogger A, Hansteen IL, et al. Cancer risk in Humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic Study Group on the Health risk of chromosome damage. Cancer Res 1994, 54: 2919–22.

    CAS  PubMed  Google Scholar 

  12. Bonassi S, Abbondandolo A, Camurri L, et al. Are chromosome aberrations in lymphocytes predictive of future cancer onset in humans? Cancer Genet Cytogenet 1995, 79: 133–5.

    Article  CAS  PubMed  Google Scholar 

  13. Flynn M, Ekstrom L, De Arce M, Hoey H. Aspects of the safety recombinant human growth hormone therapy in Turner syndrome. Proceedings of the International Symposium on Turner Syndrome, Gotemborg 18–20 May, 1995, B15, p 120 (abstract).

  14. Bozzola M, Tettoni K, Severi F, Capra E, Danesino C, Scappaticci MA. Does growth hormone treatment increase chromosomal abnormalities? Clin Endocrinol (Oxf) 1997, 47: 363–6.

    Article  CAS  Google Scholar 

  15. Slyper AH, Shadley JD, van Tuinen P, et al. A study of chromosomal aberrations and chromosomal fragility after recombinant growth hormone treatment. Ped Res 2000, 47: 634–9.

    Article  CAS  Google Scholar 

  16. Lin YW, Kubota M, Wakazono Y, et al. Normal mutation frequencies of somatic cells in patients receiving growth hormone therapy. Mutation Res 1996, 362: 97–103.

    Article  PubMed  Google Scholar 

  17. Lin YW, Kubota M, Akiyama Y, Sawada M, Furusho K. Measurement of mutation frequency at the HPRT locus in peripheral lymphocytes. Is this a good method to evaluate a cancer risk in paediatric patients? Adv Exp Med Biol 1998, 431: 681–6.

    Article  CAS  PubMed  Google Scholar 

  18. Cianfarani S, Tedeschi B, Germani D, et al. In vitro effects of growth hormone (GH) and insulin-like growth factor I and II (IGF-I and IGF-II) on chromosome fragility and p53 protein expression in human lymphocytes. Eur J Clin Invest 1998, 1: 41–7.

    Article  Google Scholar 

  19. De la Chapelle A. Testing tumors for microsatellite instability. Eur J Hum Genet. 1999, 7: 407–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Biology and Medical Genetics, University of Pavia, Pavia, Italy

    C. Olivieri, C. Danesino (Genetic Counseling) & S. Scappaticci

  2. Department of Pediatrics, University of Pavia, I.R.C.C.S. San Matteo, piazzale C. Golgi, 27100, Pavia, Italy

    C. Danesino (Genetic Counseling) &  Mauro Bozzola MD

Authors
  1. C. Olivieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Danesino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Scappaticci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mauro Bozzola MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mauro Bozzola MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Olivieri, C., Danesino, C., Scappaticci, S. et al. Can GH induce chromosome breaks or microsatellite instability in GH-deficient children?. J Endocrinol Invest 27, 308–310 (2004). https://doi.org/10.1007/BF03351053

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03351053

Key-words

Search

Navigation